A detailed history of Comerica Bank transactions in Eli Lilly & CO stock. As of the latest transaction made, Comerica Bank holds 1,511,620 shares of LLY stock, worth $1.13 Billion. This represents 5.36% of its overall portfolio holdings.

Number of Shares
1,511,620
Previous 1,512,983 0.09%
Holding current value
$1.13 Billion
Previous $1.37 Billion 2.24%
% of portfolio
5.36%
Previous 5.75%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $1.05 Million - $1.31 Million
-1,363 Reduced 0.09%
1,511,620 $1.34 Billion
Q2 2024

Aug 15, 2024

BUY
$724.87 - $909.04 $458 Million - $574 Million
631,312 Added 71.6%
1,512,983 $1.37 Billion
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $3.23 Million - $4.32 Million
-5,453 Reduced 0.61%
881,671 $686 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $128 Million - $151 Million
243,366 Added 37.8%
887,124 $517 Million
Q3 2023

Nov 21, 2023

BUY
$434.7 - $599.3 $280 Million - $386 Million
643,758 New
643,758 $346 Million
Q2 2023

Aug 22, 2023

SELL
$350.74 - $468.98 $57 Million - $76.3 Million
-162,609 Closed
0 $0
Q4 2022

Jan 26, 2023

BUY
$321.55 - $374.67 $2.68 Million - $3.12 Million
8,328 Added 5.4%
162,609 $0
Q3 2022

Oct 28, 2022

SELL
$296.48 - $337.87 $911,083 - $1.04 Million
-3,073 Reduced 1.95%
154,281 $53.7 Million
Q2 2022

Aug 02, 2022

BUY
$278.73 - $327.27 $7.03 Million - $8.25 Million
25,209 Added 19.08%
157,354 $51.3 Million
Q1 2022

Apr 27, 2022

SELL
$234.69 - $291.66 $81,672 - $101,497
-348 Reduced 0.26%
132,145 $37.8 Million
Q4 2021

Feb 18, 2022

BUY
$224.85 - $279.04 $416,871 - $517,340
1,854 Added 1.42%
132,493 $36.6 Million
Q3 2021

Nov 22, 2021

SELL
$221.6 - $272.71 $7.84 Million - $9.64 Million
-35,364 Reduced 21.3%
130,639 $30.2 Million
Q2 2021

Aug 26, 2021

SELL
$180.55 - $233.54 $513,845 - $664,654
-2,846 Reduced 1.69%
166,003 $38.1 Million
Q1 2021

Apr 28, 2021

SELL
$164.32 - $212.72 $3.11 Million - $4.03 Million
-18,934 Reduced 10.08%
168,849 $31.5 Million
Q4 2020

Jan 28, 2021

SELL
$130.46 - $172.63 $1.05 Million - $1.39 Million
-8,023 Reduced 4.1%
187,783 $31.7 Million
Q3 2020

Oct 30, 2020

SELL
$146.22 - $169.13 $1.89 Million - $2.19 Million
-12,939 Reduced 6.2%
195,806 $29 Million
Q2 2020

Jul 31, 2020

BUY
$136.42 - $164.18 $2.53 Million - $3.05 Million
18,559 Added 9.76%
208,745 $34.3 Million
Q1 2020

May 01, 2020

SELL
$119.05 - $147.35 $812,397 - $1.01 Million
-6,824 Reduced 3.46%
190,186 $26.4 Million
Q4 2019

Feb 07, 2020

SELL
$106.92 - $132.43 $455,586 - $564,284
-4,261 Reduced 2.12%
197,010 $25.9 Million
Q3 2019

Oct 31, 2019

SELL
$106.79 - $116.16 $216,249 - $235,224
-2,025 Reduced 1.0%
201,271 $22.5 Million
Q2 2019

Aug 02, 2019

SELL
$110.79 - $129.32 $521,266 - $608,450
-4,705 Reduced 2.26%
203,296 $0
Q1 2019

May 02, 2019

SELL
$111.31 - $131.02 $3.47 Million - $4.09 Million
-31,183 Reduced 13.04%
208,001 $0
Q4 2018

Feb 06, 2019

BUY
$105.9 - $118.64 $460,029 - $515,372
4,344 Added 1.85%
239,184 $27.7 Million
Q3 2018

Nov 01, 2018

SELL
$85.86 - $107.31 $4.63 Million - $5.78 Million
-53,882 Reduced 18.66%
234,840 $25.9 Million
Q2 2018

Aug 01, 2018

BUY
$75.7 - $86.88 $1.13 Million - $1.3 Million
14,954 Added 5.46%
288,722 $25.9 Million
Q1 2018

May 01, 2018

SELL
$74.21 - $87.6 $2.11 Million - $2.49 Million
-28,369 Reduced 9.39%
273,768 $21.8 Million
Q4 2017

Feb 02, 2018

SELL
$81.94 - $87.89 $59,898 - $64,247
-731 Reduced 0.24%
302,137 $25.5 Million
Q3 2017

Nov 06, 2017

BUY
$77.07 - $85.54 $23.3 Million - $25.9 Million
302,868
302,868 $25 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.